MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-09-0002009
Market Cap
₹23.48 Cr
WALPAR-SM · NSE
Share Price
₹25.00
0.00% today
Revenue
₹78.79 Cr
FY 2025-26 · +9.8% YoY
EBITDA
₹6.66 Cr
Margin 8.4%
Net Profit
₹2.48 Cr
FY 2025-26 · +6.4% YoY
P/E (TTM)
9.5x
P/B 1.2x
ROE
18.1%
ROCE 16.3%
Debt / Equity
0.69
Interest cover 17.2x
About Walpar Nutritions Limited
Data last updated:
Walpar Nutritions Limited is a public limited company based in Gandhinagar, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24230GJ2020PLC118662. Its GSTIN is 24AACCW8245J1Z2 (Gujarat). The company holds 3 GST registrations, all of them active. It is a listed company as per MCA records. Its shares are listed on NSE: WALPAR.
The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹9.39 Cr. It is led by directors including Kalpesh Pravinchandra Ladhawala (Managing Director) and Tanmaykumar Ashwinbhai Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 2nd Floor L5:377 Plot:5 Opp. Sabarmati Village: Khatraj Taluka: Kalol, Gandhinagar, Gujarat, India – 382721.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹78.79 Cr, a growth of 9.8% compared to the previous year. For the same year it recorded a net profit of ₹2.48 Cr (net margin 3.1%) and EBITDA of ₹6.66 Cr (EBITDA margin 8.5%). The net worth stands at ₹18.9 Cr (up 14.1% YoY). Total assets are valued at ₹38.91 Cr (up 43.5% YoY).
The company has about 24 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand: Walpar Nutritions. As per MCA filings, the company has open charges of ₹6.89 Cr and satisfied charges of ₹6.07 Cr on record. The company has 3 deals on record (1 ipo, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹1.71 Cr; the latest was in July 2021. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Srikar Laboratories Private Limited with revenue of ₹72.62 Cr.
Walpar Nutritions Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-09-0002009). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website walparnutritions.com.
Company details
CIN L24230GJ2020PLC118662
Registration Number 118662
Incorporation Date 04 December 2020
ROC Ahmedabad
Listing Status Listed (NSE: WALPAR)
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-09-0002009
CIN history
Walpar Nutritions has one previous CIN (Corporate Identification Number): U24230GJ2020PLC118662. The current CIN is L24230GJ2020PLC118662, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24230GJ2020PLC118662 | Current |
| U24230GJ2020PLC118662 | Previous |
Key People
Kalpesh Pravinchandra Ladhawala Managing Director Tanmaykumar Ashwinbhai Shah Whole-Time Director Nidhi Yogeshkumar Shah Director Recognitions & Rankings of Walpar Nutritions
Contact details
Walpar Nutritions Limited's registered office is in Gandhinagar, Gujarat. Its website is walparnutritions.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address2nd Floor L5:377 Plot:5 Opp. Sabarmati Village: Khatraj Taluka: Kalol, Gandhinagar, Gujarat, India – 382721
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Walpar Nutritions Limited, buy the company report.
Comprehensive company report
Walpar Nutritions Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Walpar Nutritions operates one associated brand: Walpar Nutritions. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Tablets, capsules, and nutraceutical products are manufactured as a CDMO. | walparnutritions.com |
Business activity
The main business activity of Walpar Nutritions is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Walpar Nutritions Limited, buy the company report.
Financials of Walpar Nutritions Limited
FY 2025-26 filings availableWalpar Nutritions Limited reported revenue of ₹78.79 Cr (up 9.8% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue
₹78.79 Cr
+9.8% YoY
EBITDA
₹6.66 Cr
+16.4% YoY
Profit After Tax
₹2.48 Cr
+6.4% YoY
Net Worth
₹18.90 Cr
+14.1% YoY
Total Assets
₹38.91 Cr
+43.5% YoY
Total Debt
₹16.77 Cr
+113.6% YoY
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 78.79 | 71.76 | 62.52 | 35.14 | 26.76 | 6.07 |
| Revenue growth | +9.8% | +14.8% | +77.9% | +31.3% | +340.9% | - |
| EBITDA | 6.66 | 5.72 | 4.75 | 3.47 | 1.01 | 0.45 |
| EBITDA margin | +8.5% | +8.0% | +7.6% | +9.9% | +3.8% | +7.4% |
| Profit before tax | 4.10 | 3.88 | 2.49 | 1.11 | 0.29 | 0.15 |
| Net profit | 2.48 | 2.33 | 1.53 | 0.60 | 0.41 | 0.14 |
| Net profit margin | +3.2% | +3.3% | +2.5% | +1.7% | +1.5% | +2.3% |
| EPS (₹) | 2.64 | 2.48 | 3.37 | 1.30 | 0.84 | 0.45 |
| Balance sheet | ||||||
| Total assets | 38.91 | 27.12 | 24.72 | 23.89 | 19.86 | 12.30 |
| Net worth | 18.90 | 16.56 | 14.19 | 11.71 | 10.99 | 4.78 |
| Total debt | 16.77 | 7.85 | 8.30 | 10.30 | 7.25 | 7.49 |
| Cash & bank | 4.93 | 1.59 | 0.51 | 0.54 | 0.46 | 0.98 |
| Net working capital | 21.55 | 14.20 | 12.21 | 13.19 | 10.59 | 9.09 |
| Cash flow | ||||||
| Cash from operations | 1.83 | 4.06 | 5.35 | 1.10 | (1.08) | (0.31) |
| Cash from investing | (6.57) | (2.30) | (3.61) | (3.44) | (6.14) | (2.02) |
| Cash from financing | 8.08 | (0.68) | (1.77) | 2.42 | 6.71 | 2.95 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 65.30 | 60.16 | 51.31 | 28.70 | 26.76 | 6.07 | 16.71 |
| Revenue growth | +8.5% | +17.3% | +78.8% | +7.3% | +340.9% | -63.7% | - |
| EBITDA | 2.91 | 2.83 | 1.76 | 0.78 | 1.06 | 0.45 | 1.22 |
| EBITDA margin | +4.5% | +4.7% | +3.4% | +2.7% | +4.0% | +7.4% | +7.3% |
| Profit before tax | 2.53 | 2.42 | 1.47 | 0.46 | 0.34 | 0.15 | 0.20 |
| Net profit | 1.98 | 1.68 | 1.06 | 0.30 | 0.44 | 0.14 | 0.13 |
| Net profit margin | +3.0% | +2.8% | +2.1% | +1.1% | +1.6% | +2.3% | +0.8% |
| EPS (₹) | 2.09 | 1.80 | 2.37 | 0.65 | 0.92 | 0.45 | 0.63 |
| Balance sheet | |||||||
| Total assets | 18.89 | 15.02 | 13.65 | 14.52 | 15.41 | 10.24 | 9.11 |
| Net worth | 16.98 | 15.02 | 13.34 | 11.32 | 11.03 | 4.78 | 3.23 |
| Total debt | 1.91 | 0.00 | 0.32 | 3.21 | 4.38 | 5.46 | 5.88 |
| Cash & bank | 0.86 | 1.51 | 0.45 | 0.37 | 0.34 | 0.97 | 0.45 |
| Net working capital | 8.58 | 7.96 | 7.28 | 8.84 | 8.97 | 8.28 | 7.71 |
| Cash flow | |||||||
| Cash from operations | 1.15 | 2.71 | 3.13 | 1.09 | (0.32) | 1.38 | 0.40 |
| Cash from investing | (3.62) | (1.23) | (0.88) | 0.46 | (4.58) | (0.70) | 0.00 |
| Cash from financing | 1.82 | (0.42) | (2.18) | (1.52) | 4.27 | (0.06) | (0.24) |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 31 Oct 2026
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Revenue | 78.79 | 71.76 | 62.52 | 35.14 | 26.76 | 6.07 |
| Revenue growth | +9.8% | +14.8% | +77.9% | +31.3% | +340.9% | - |
| Other income | 0.26 | 0.27 | 0.22 | 0.34 | 0.04 | 0.00 |
| Total expenses | 72.13 | 66.04 | 57.77 | 31.67 | 25.75 | 5.62 |
| Employee cost | 6.03 | 3.70 | 3.17 | 3.14 | 2.11 | 0.61 |
| EBITDA | 6.66 | 5.72 | 4.75 | 3.47 | 1.01 | 0.45 |
| EBITDA margin | +8.5% | +8.0% | +7.6% | +9.9% | +3.8% | +7.4% |
| Depreciation | 2.02 | 1.82 | 1.81 | 1.91 | 0.28 | 0.12 |
| Interest | 0.80 | 0.29 | 0.67 | 0.79 | 0.48 | 0.18 |
| Profit before tax | 4.10 | 3.88 | 2.49 | 1.11 | 0.29 | 0.15 |
| Tax | 0.89 | 1.08 | 0.55 | 0.30 | (0.09) | 0.01 |
| Net profit | 2.48 | 2.33 | 1.53 | 0.60 | 0.41 | 0.14 |
| Net profit margin | +3.2% | +3.3% | +2.5% | +1.7% | +1.5% | +2.3% |
| EPS (₹) | 2.64 | 2.48 | 3.37 | 1.30 | 0.84 | 0.45 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Equity & liabilities | ||||||
| Share capital | 9.39 | 9.39 | 4.70 | 4.54 | 4.54 | 3.34 |
| Reserves & surplus | 9.51 | 7.17 | 9.49 | 7.17 | 6.45 | 1.44 |
| Shareholders' funds (net worth) | 18.90 | 16.56 | 14.19 | 11.71 | 10.99 | 4.78 |
| Minority interest | 3.24 | 2.72 | 2.24 | 1.88 | 1.61 | 0.03 |
| Secured loans | 15.10 | 6.95 | 6.54 | 7.86 | 4.64 | 2.75 |
| Unsecured loans | 1.67 | 0.90 | 1.76 | 2.44 | 2.61 | 4.74 |
| Total debt | 16.77 | 7.85 | 8.30 | 10.30 | 7.25 | 7.49 |
| Total liabilities | 38.91 | 27.12 | 24.72 | 23.89 | 19.86 | 12.30 |
| Assets | ||||||
| Gross block | 20.72 | 17.15 | 14.88 | 13.03 | 2.41 | 1.82 |
| Net block | 12.21 | 10.65 | 10.20 | 10.13 | 2.01 | 1.70 |
| Capital work in progress | 0.05 | 0.03 | 0.02 | 0.02 | 4.48 | 1.22 |
| Investments | 2.88 | 1.88 | 1.88 | 0.02 | 0.49 | 0.00 |
| Inventories | 15.26 | 10.53 | 9.16 | 8.50 | 5.93 | 4.33 |
| Sundry debtors | 23.45 | 21.18 | 13.44 | 12.48 | 9.11 | 7.16 |
| Cash & bank balances | 4.93 | 1.59 | 0.51 | 0.54 | 0.46 | 0.98 |
| Loans & advances | 5.06 | 1.15 | 1.54 | 2.08 | 3.32 | 2.32 |
| Total current assets | 48.70 | 34.45 | 24.65 | 23.60 | 18.82 | 14.79 |
| Total current liabilities | 27.15 | 20.25 | 12.44 | 10.41 | 8.23 | 5.70 |
| Net working capital | 21.55 | 14.20 | 12.21 | 13.19 | 10.59 | 9.09 |
| Total assets | 38.91 | 27.12 | 24.72 | 23.89 | 19.86 | 12.30 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Opening cash | 1.59 | 0.51 | 0.54 | 0.46 | 0.98 | 0.35 |
| Net cash from operating activities | 1.83 | 4.06 | 5.35 | 1.10 | (1.08) | (0.31) |
| Net cash from investing activities | (6.57) | (2.30) | (3.61) | (3.44) | (6.14) | (2.02) |
| Net cash from financing activities | 8.08 | (0.68) | (1.77) | 2.42 | 6.71 | 2.95 |
| Net change in cash | 3.34 | 1.08 | (0.03) | 0.07 | (0.51) | 0.62 |
| Closing cash | 4.93 | 1.59 | 0.51 | 0.54 | 0.46 | 0.98 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Growth | ||||||
| Sales growth | +9.8% | +14.8% | +77.9% | +31.3% | +340.9% | - |
| EBITDA growth | +16.4% | +20.4% | +36.9% | +243.6% | +124.4% | - |
| PBT growth | +5.7% | +55.8% | +124.3% | +282.8% | +93.3% | +9997.0% |
| Net income growth | +6.4% | +52.3% | +155.0% | +46.3% | +192.9% | - |
| Revenue CAGR (3Y) | +30.9% | +38.9% | +117.6% | - | - | - |
| EBITDA CAGR (3Y) | +24.3% | +78.3% | +119.4% | - | - | - |
| Profitability & leverage | ||||||
| Net income margin | +4.1% | +3.9% | +3.1% | +2.3% | +1.4% | +2.3% |
| Return on capital employed | +16.3% | +17.8% | +14.3% | +9.4% | +5.0% | +2.8% |
| Return on net worth | +18.1% | +18.2% | +15.1% | +7.1% | +4.6% | +3.1% |
| Debt / equity | 0.69 | 0.53 | 0.72 | 0.77 | 0.93 | 1.57 |
| Long-term debt / equity | 0.37 | 0.27 | 0.39 | 0.34 | 0.40 | 0.97 |
| Interest cover | 17.24 | 7.44 | 22.79 | 50.64 | 65.75 | 54.55 |
| Efficiency & per share | ||||||
| Fixed asset turnover | 4.16 | 4.48 | 4.48 | 4.55 | 12.65 | 3.34 |
| Inventory turnover | 6.11 | 7.29 | 7.08 | 4.87 | 5.22 | 1.40 |
| Debtors turnover | 3.53 | 4.15 | 4.82 | 3.26 | 3.29 | 0.85 |
| EPS (₹) | 2.64 | 2.48 | 3.37 | 1.30 | 0.84 | 0.45 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 20.13 | 17.63 | 30.21 | 25.80 | 24.21 | 14.30 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 65.30 | 60.16 | 51.31 | 28.70 | 26.76 | 6.07 | 16.71 |
| Revenue growth | +8.5% | +17.3% | +78.8% | +7.3% | +340.9% | -63.7% | - |
| Other income | 0.14 | 0.10 | 0.13 | 0.27 | 0.04 | 0.00 | 0.00 |
| Total expenses | 62.39 | 57.33 | 49.55 | 27.92 | 25.70 | 5.62 | 15.49 |
| Employee cost | 0.90 | 1.03 | 0.97 | 0.96 | 2.11 | 0.61 | 2.56 |
| EBITDA | 2.91 | 2.83 | 1.76 | 0.78 | 1.06 | 0.45 | 1.22 |
| EBITDA margin | +4.5% | +4.7% | +3.4% | +2.7% | +4.0% | +7.4% | +7.3% |
| Depreciation | 0.43 | 0.41 | 0.21 | 0.25 | 0.28 | 0.12 | 0.29 |
| Interest | 0.09 | 0.10 | 0.21 | 0.34 | 0.48 | 0.18 | 0.73 |
| Profit before tax | 2.53 | 2.42 | 1.47 | 0.46 | 0.34 | 0.15 | 0.20 |
| Tax | 0.55 | 0.74 | 0.36 | 0.16 | (0.09) | 0.01 | 0.07 |
| Net profit | 1.98 | 1.68 | 1.06 | 0.30 | 0.44 | 0.14 | 0.13 |
| Net profit margin | +3.0% | +2.8% | +2.1% | +1.1% | +1.6% | +2.3% | +0.8% |
| EPS (₹) | 2.09 | 1.80 | 2.37 | 0.65 | 0.92 | 0.45 | 0.63 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 9.39 | 9.39 | 4.70 | 4.54 | 4.54 | 3.34 | 3.00 |
| Reserves & surplus | 7.59 | 5.63 | 8.64 | 6.78 | 6.49 | 1.44 | 0.23 |
| Shareholders' funds (net worth) | 16.98 | 15.02 | 13.34 | 11.32 | 11.03 | 4.78 | 3.23 |
| Secured loans | 1.91 | 0.00 | 0.32 | 1.95 | 1.81 | 2.75 | 0.75 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 1.26 | 2.57 | 2.71 | 5.13 |
| Total debt | 1.91 | 0.00 | 0.32 | 3.21 | 4.38 | 5.46 | 5.88 |
| Total liabilities | 18.89 | 15.02 | 13.65 | 14.52 | 15.41 | 10.24 | 9.11 |
| Assets | |||||||
| Gross block | 4.18 | 3.52 | 2.30 | 1.48 | 1.34 | 1.18 | 2.13 |
| Net block | 2.52 | 2.29 | 1.48 | 0.83 | 0.94 | 1.06 | 1.14 |
| Capital work in progress | 0.05 | 0.03 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 |
| Investments | 5.06 | 4.70 | 4.70 | 2.84 | 2.93 | 0.06 | 0.00 |
| Inventories | 7.58 | 4.77 | 5.03 | 6.04 | 5.93 | 4.33 | 4.03 |
| Sundry debtors | 19.91 | 16.95 | 10.09 | 8.78 | 9.11 | 7.16 | 8.39 |
| Cash & bank balances | 0.86 | 1.51 | 0.45 | 0.37 | 0.34 | 0.97 | 0.45 |
| Loans & advances | 1.27 | 0.62 | 1.56 | 0.98 | 1.53 | 1.27 | 0.28 |
| Total current assets | 29.62 | 23.85 | 17.13 | 16.17 | 16.91 | 13.73 | 13.15 |
| Total current liabilities | 21.04 | 15.89 | 9.85 | 7.33 | 7.94 | 5.45 | 5.44 |
| Net working capital | 8.58 | 7.96 | 7.28 | 8.84 | 8.97 | 8.28 | 7.71 |
| Total assets | 18.89 | 15.02 | 13.65 | 14.52 | 15.41 | 10.24 | 9.11 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 1.51 | 0.45 | 0.37 | 0.34 | 0.97 | 0.35 | 0.28 |
| Net cash from operating activities | 1.15 | 2.71 | 3.13 | 1.09 | (0.32) | 1.38 | 0.40 |
| Net cash from investing activities | (3.62) | (1.23) | (0.88) | 0.46 | (4.58) | (0.70) | 0.00 |
| Net cash from financing activities | 1.82 | (0.42) | (2.18) | (1.52) | 4.27 | (0.06) | (0.24) |
| Net change in cash | (0.65) | 1.06 | 0.07 | 0.03 | (0.63) | 0.62 | 0.17 |
| Closing cash | 0.86 | 1.51 | 0.45 | 0.37 | 0.34 | 0.97 | 0.45 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +8.5% | +17.3% | +78.8% | +7.3% | +340.9% | -63.7% | - |
| EBITDA growth | +2.8% | +60.8% | +125.6% | -26.4% | +135.6% | -63.1% | - |
| PBT growth | +4.6% | +64.6% | +219.6% | +35.3% | +126.7% | +9997.0% | +9997.0% |
| Net income growth | +17.9% | +58.5% | +253.3% | -31.8% | +214.3% | +7.7% | - |
| Revenue CAGR (3Y) | +31.5% | +31.0% | +103.7% | +171.8% | +25.4% | - | - |
| EBITDA CAGR (3Y) | +55.1% | +38.7% | +57.6% | +27.1% | -6.5% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +3.0% | +2.8% | +2.2% | +1.1% | +1.6% | +2.3% | +0.8% |
| Return on capital employed | +15.4% | +17.6% | +12.0% | +5.3% | +6.4% | +3.3% | +12.3% |
| Return on net worth | +12.3% | +11.9% | +9.0% | +2.6% | +5.3% | +3.1% | +6.2% |
| Debt / equity | 0.06 | 0.01 | 0.14 | 0.34 | 0.62 | 1.14 | 2.88 |
| Long-term debt / equity | 0.00 | 0.00 | 0.04 | 0.12 | 0.27 | -0.06 | 1.37 |
| Interest cover | 3.63 | 4.13 | 13.55 | 64.15 | 61.54 | 54.55 | 78.49 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 16.96 | 20.67 | 27.15 | 20.35 | 21.24 | 5.14 | 8.94 |
| Inventory turnover | 10.57 | 12.28 | 9.27 | 4.80 | 5.22 | 1.40 | 4.40 |
| Debtors turnover | 3.54 | 4.45 | 5.44 | 3.21 | 3.29 | 0.85 | 2.27 |
| EPS (₹) | 2.09 | 1.80 | 2.37 | 0.65 | 0.92 | 0.45 | 0.63 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 18.08 | 15.99 | 28.40 | 24.92 | 24.29 | 14.30 | 10.00 |
To see the full year-wise statements and ratios of Walpar Nutritions Limited, buy the company report.
Board of directors of Walpar Nutritions Limited
Walpar Nutritions has 9 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tanmaykumar Ashwinbhai Shah | Whole-Time Director | 04 Dec 2020 | 5 Years 10 Months | Current |
| Kalpesh Pravinchandra Ladhawala Also directs: Walpar Bio Sciences LLP, Pallota Nutritions Private Limited, Steer Peau Dermo Cosmetique Private Limited and 3 more | Managing Director | 04 Dec 2020 | 5 Years 10 Months | Current |
| Nidhi Yogeshkumar Shah | Director | 24 Dec 2020 | 5 Years 10 Months | Current |
| Fenil Prakashkumar Shah | Director | 29 Dec 2020 | 5 Years 10 Months | Current |
| Sejal Kalpesh Ladhawala Also directs: Walpar Bio Sciences LLP, Walpar Wellness Private Limited | Director | 04 Dec 2020 | 5 Years 10 Months | Current |
| Rupesh Himatlal Shah Also directs: Das Digisol LLP | Director | 13 Feb 2021 | 5 Years 8 Months | Current |
Showing 6 of 9 current directors. View all directors
Peer comparison
Walpar Nutritions Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Walpar Nutritions Limitedthis company | ₹78.79 Cr (FY 2026) | ₹2.48 Cr | 3.1% | 9.8% | 24 | Gandhinagar, Gujarat, India |
| Srikar Laboratories Private Limited | ₹72.62 Cr (FY 2025) | -10.0% | Hyderabad, Telangana, India | |||
| Elan Pharma (India) Private Limited | ₹72.61 Cr (FY 2025) | 12.0% | Mumbai, Maharashtra, India | |||
| Vance and Health Pharmaceuticals Private Limited | ₹72.08 Cr (FY 2025) | 17.0% | Hyderabad, Telangana, India | |||
| Momentum Biotech Private Limited | ₹71.34 Cr (FY 2025) | 147.0% | Jaipur, Rajasthan, India | |||
| Synnat Pharma Private Limited | ₹71.34 Cr (FY 2024) | 12.0% | Hyderabad, Telangana, India | |||
| Sanjivani Paranteral Limited | ₹71.31 Cr (FY 2025) | 30.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Walpar Nutritions Limited, buy the company report.
Auditor
Walpar Nutritions Limited is audited by A Y & Company for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A Y & Company | FY 2024 | 020829C |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 68.80%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 31.20%.
Sep 2026
QUARTER
68.80% Promoters
31.20% Retail & Others
Promoter holding - history
Now 68.80% · Sep 2026High 68.80% · Sep 2026Low 68.50% · Dec 2025
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 68.80% | 68.60% | 68.50% | 68.50% |
| Public | 31.20% | 31.40% | 31.50% | 31.50% |
Charges & borrowings
Open charges
₹6.89 Cr
Satisfied charges
₹6.07 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Jun 2026 | 101332399 | Others | ₹39.21 Lakh | Open | |
| 31 Jan 2026 | 101275749 | Others | ₹1.5 Cr | Open | |
| 31 Jan 2026 | 101275861 | Others | ₹1 Cr | Open | |
| 10 Jul 2025 | 101123275 | Others | ₹4 Cr | Open | |
| 19 Oct 2022 | 100626026 | Hdfc Bank Limited | ₹1.5 Cr | Satisfied |
To see the full charge records of Walpar Nutritions Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Walpar Nutritions Limited has 3 deals on record (1 ipo, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹1.71 Cr; the latest was in July 2021.
Total deals
3
IPO
1
Funding round
1
Secondary share transfer
1
Disclosed funding
₹1.71 Cr
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2021 | IPO | ₹6.6 Cr | Investors: Ipo -Walpar Nutritions Limited, Nikunj Stock Brokers Limited , 2 individuals |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Jan 2021 | Funding round | ₹1.71 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Walpar Nutritions Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Walpar Nutritions Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Walpar Nutritions has 2 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
2
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Walpar Wellness Private Limited | U24239GJ2021PTC119317 | |
| Walpar Nutri Science Private Limited | U36999GJ2020PTC112235 |
To see the full group structure of Walpar Nutritions Limited, buy the company report.
Employees & EPFO
Walpar Nutritions Limited has a workforce of 24 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
24
Active EPFO establishments
1
Employee growth
-7.69%
GST
Walpar Nutritions has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCW8245J1Z2 | Gujarat | Active | 04 Dec 2020 |
| 06AACCW8245J1Z0 | Haryana | Active | 09 Apr 2021 |
| 29AACCW8245J1ZS | Karnataka | Active | 12 Aug 2021 |
To see the full GST registrations and return filing status of Walpar Nutritions Limited, buy the company report.
Recent activity
Walpar Nutritions Limited has 20 board changes on record since 2020: 16 appointments and 4 cessations. The latest: Priyanka Joshi ceased to be Company Secretary on 13 Jan 2025.
Charges
A charge with Others of Rs. 4.00 Cr registered on 10 Jul 2025 with Charge ID 101123275 was modified on 04 Jul 2026.
Charges
A charge with Others amounted to Rs. 0.39 Cr with Charge ID 101332399 was registered on 22 Jun 2026.
Filing
Walpar Nutritions Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101275749 was registered on 31 Jan 2026.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 101275861 was registered on 31 Jan 2026.
AGM
Walpar Nutritions Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 4.00 Cr with Charge ID 101123275 was registered on 10 Jul 2025.
Charges
A charge registered on 19 Oct 2022 via Charge ID 100626026 with Hdfc Bank Limited was fully satisfied on 12 Mar 2025.
Ceased
Priyanka Joshi ceased to be Company Secretary.
Ceased
Megha Ravikumar Shah ceased to be Director.
Charges
A charge with Hdfc Bank Limited of Rs. 1.50 Cr registered on 19 Oct 2022 with Charge ID 100626026 was modified on 23 Feb 2024.
Ceased
Divyanshu Subhashchandra Raval ceased to be Director.
23 earlier events are in the company report.
Frequently asked questions
Walpar Nutritions is an active public limited company based in Gandhinagar, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 December 2020 (6+ years old) and is registered under CIN L24230GJ2020PLC118662. Listed on NSE: WALPAR.
Walpar Nutritions reported revenue of ₹78.79 Cr for FY 2025-26 (up 9.8% YoY) based on consolidated financials.
Walpar Nutritions has 9 current directors:
- Kalpesh Pravinchandra Ladhawala - Managing Director
- Tanmaykumar Ashwinbhai Shah - Whole-Time Director
- Nidhi Yogeshkumar Shah - Director
- Fenil Prakashkumar Shah - Director
- Sejal Kalpesh Ladhawala - Director
- Rupesh Himatlal Shah - Director
- Jayshukh Ramjibhai Detroja - Director
- Tapan Natverlal Patel - Director
- Nehalkumar Shah - Director
The latest financial statements of Walpar Nutritions on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Walpar Nutritions is 24AACCW8245J1Z2, registered in Gujarat. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 06AACCW8245J1Z0 (Haryana), 29AACCW8245J1ZS (Karnataka).
The CIN (Corporate Identification Number) of Walpar Nutritions is L24230GJ2020PLC118662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Walpar Nutritions is a listed company as per MCA records. Its shares are listed on NSE (symbol: WALPAR).
Walpar Nutritions was incorporated on 04 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Walpar Nutritions has 3 deals on record (1 ipo, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹1.71 Cr; the latest was in July 2021.
The peers of Walpar Nutritions by revenue are Srikar Laboratories Private Limited, Elan Pharma (India) Private Limited, Vance and Health Pharmaceuticals Private Limited, Momentum Biotech Private Limited, Synnat Pharma Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Priyanka Joshi ceased to be Company Secretary on 13 Jan 2025. Megha Ravikumar Shah ceased to be Director on 05 Jul 2024. Divyanshu Subhashchandra Raval ceased to be Director on 08 Nov 2023. Walpar Nutritions has 20 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages